Cargando…

Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration

The inertness of synthetic polymer materials and the insufficient mechanical strength of reprocessed decellularized extracellular matrix (dECM) limited their promotive efforts on tissue regeneration. Here, we prepared a hybrid scaffold composed of PCL microfibers and human placental extracellular ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Siyang, Yao, Liying, Wang, Yumeng, Li, Yi, Jia, Yanju, Yang, Yueyue, Li, Na, Hu, Yuanjing, Kong, Deling, Dong, Xianhao, Wang, Kai, Zhu, Meifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486249/
https://www.ncbi.nlm.nih.gov/pubmed/36185748
http://dx.doi.org/10.1016/j.bioactmat.2022.08.018
_version_ 1784792237340622848
author Liu, Siyang
Yao, Liying
Wang, Yumeng
Li, Yi
Jia, Yanju
Yang, Yueyue
Li, Na
Hu, Yuanjing
Kong, Deling
Dong, Xianhao
Wang, Kai
Zhu, Meifeng
author_facet Liu, Siyang
Yao, Liying
Wang, Yumeng
Li, Yi
Jia, Yanju
Yang, Yueyue
Li, Na
Hu, Yuanjing
Kong, Deling
Dong, Xianhao
Wang, Kai
Zhu, Meifeng
author_sort Liu, Siyang
collection PubMed
description The inertness of synthetic polymer materials and the insufficient mechanical strength of reprocessed decellularized extracellular matrix (dECM) limited their promotive efforts on tissue regeneration. Here, we prepared a hybrid scaffold composed of PCL microfibers and human placental extracellular matrix (pECM) nanofibers by co-electrospinning, which was grafted with heparin and further absorbed with IL-4. The hybrid scaffold with improved hemocompatibility firstly switched macrophages to anti-inflammatory phenotype (increased by 18.1%) and then promoted migration, NO production, tube formation of endothelial cells (ECs), and migration and maturation of vascular smooth muscle cells (VSMCs), and ECM deposition in vitro and in vivo. ECs coverage rate increased by 8.6% and the thickness of the smooth muscle layer was 1.8 times more than PCL grafts at 12 wks. Our study realized the complementary advantages of synthetic polymer materials and dECM materials, and opened intriguing perspectives for the design and construction of small-diameter vascular grafts (SDVGs) and immune-regulated materials for other tissue regeneration.
format Online
Article
Text
id pubmed-9486249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-94862492022-09-30 Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration Liu, Siyang Yao, Liying Wang, Yumeng Li, Yi Jia, Yanju Yang, Yueyue Li, Na Hu, Yuanjing Kong, Deling Dong, Xianhao Wang, Kai Zhu, Meifeng Bioact Mater Article The inertness of synthetic polymer materials and the insufficient mechanical strength of reprocessed decellularized extracellular matrix (dECM) limited their promotive efforts on tissue regeneration. Here, we prepared a hybrid scaffold composed of PCL microfibers and human placental extracellular matrix (pECM) nanofibers by co-electrospinning, which was grafted with heparin and further absorbed with IL-4. The hybrid scaffold with improved hemocompatibility firstly switched macrophages to anti-inflammatory phenotype (increased by 18.1%) and then promoted migration, NO production, tube formation of endothelial cells (ECs), and migration and maturation of vascular smooth muscle cells (VSMCs), and ECM deposition in vitro and in vivo. ECs coverage rate increased by 8.6% and the thickness of the smooth muscle layer was 1.8 times more than PCL grafts at 12 wks. Our study realized the complementary advantages of synthetic polymer materials and dECM materials, and opened intriguing perspectives for the design and construction of small-diameter vascular grafts (SDVGs) and immune-regulated materials for other tissue regeneration. KeAi Publishing 2022-09-18 /pmc/articles/PMC9486249/ /pubmed/36185748 http://dx.doi.org/10.1016/j.bioactmat.2022.08.018 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Liu, Siyang
Yao, Liying
Wang, Yumeng
Li, Yi
Jia, Yanju
Yang, Yueyue
Li, Na
Hu, Yuanjing
Kong, Deling
Dong, Xianhao
Wang, Kai
Zhu, Meifeng
Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
title Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
title_full Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
title_fullStr Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
title_full_unstemmed Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
title_short Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
title_sort immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486249/
https://www.ncbi.nlm.nih.gov/pubmed/36185748
http://dx.doi.org/10.1016/j.bioactmat.2022.08.018
work_keys_str_mv AT liusiyang immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT yaoliying immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT wangyumeng immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT liyi immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT jiayanju immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT yangyueyue immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT lina immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT huyuanjing immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT kongdeling immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT dongxianhao immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT wangkai immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration
AT zhumeifeng immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration